|
1
|
Psychoyos A: Hormonal control of
ovoimplantation. Vitam Horm. 31:201–256. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nikas G: Endometrial receptivity: changes
in cell-surface morphology. Semin Reprod Med. 18:229–235. 2000.
View Article : Google Scholar
|
|
3
|
Simón C, Martín JC and Pellicer A:
Paracrine regulators of implantation. Baillieres Best Pract Res
Clin Obstet Gynaecol. 14:815–826. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Escary JL, Perreau J, Duménil D, Ezine S
and Brûlet P: Leukaemia inhibitory factor is necessary for
maintenance of haematopoietic stem cells and thymocyte stimulation.
363:361–364. 1993.PubMed/NCBI
|
|
5
|
Cavagna M and Mantese JC: Biomarkers of
endometrial receptivity - a review. Placenta. 24(Suppl B): S39–S47.
2003. View Article : Google Scholar
|
|
6
|
Hoozemans DA, Schats R, Lambalk CB,
Homburg R and Hompes PG: Human embryo implantation: current
knowledge and clinical implications in assisted reproductive
technology. Reprod Biomed Online. 9:692–715. 2004. View Article : Google Scholar
|
|
7
|
Stewart CL, Kaspar P, Brunet LJ, et al:
Blastocyst implantation depends on maternal expression of leukaemia
inhibitory factor. Nature. 359:76–79. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dimitriadis E, Nie G, Hannan NJ, Paiva P
and Salamonsen LA: Local regulation of implantation at the human
fetal-maternal interface. Int J Dev Biol. 54:313–322. 2010.
View Article : Google Scholar
|
|
9
|
Fiedler U, Reiss Y, Scharpfenecker M, et
al: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and
has a crucial role in the induction of inflammation. Nat Med.
12:235–239. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maisonpierre PC, Suri C, Jones PF, et al:
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo
angiogenesis. Science. 277:55–60. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsumoto H, Ma WG, Daikoku T, et al:
Cyclooxygenase-2 differentially directs uterine angiogenesis during
implantation in mice. J Biol Chem. 277:29260–29267. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Mouzon J, Goossens V, Bhattacharya S,
et al; European IVF-monitoring (EIM) Consortium, for the European
Society of Human Reproduction and Embryology (ESHRE). Assisted
reproductive technology in Europe, 2006: results generated from
European registers by ESHRE. Hum Reprod. 25:1851–1862. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papanikolaou EG, Bourgain C, Kolibianakis
E, Tournaye H and Devroey P: Steroid receptor expression in late
follicular phase endometrium in GnRH antagonist IVF cycles is
already altered, indicating initiation of early luteal phase
transformation in the absence of secretory changes. Hum Reprod.
20:1541–1547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fauser BC and Devroey P: Reproductive
biology and IVF: ovarian stimulation and luteal phase consequences.
Trends Endocrinol Metab. 14:236–242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saadat P, Boostanfar R, Slater CC,
Tourgeman DE, Stanczyk FZ and Paulson RJ: Accelerated endometrial
maturation in the luteal phase of cycles utilizing controlled
ovarian hyperstimulation: impact of gonadotropin-releasing hormone
agonists versus antagonists. Fertil Steril. 82:167–171. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kolibianakis E, Bourgain C, Albano C, et
al: Effect of ovarian stimulation with recombinant
follicle-stimulating hormone, gonadotropin releasing hormone
antagonists, and human chorionic gonadotropin on endometrial
maturation on the day of oocyte pick-up. Fertil Steril.
78:1025–1029. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pellicer A, Valbuena D, Cano F, Remohí J
and Simón C: Lower implantation rates in high responders: evidence
for an altered endocrine milieu during the preimplantation period.
Fertil Steril. 65:1190–1195. 1996.PubMed/NCBI
|
|
18
|
Check JH, Choe JK, Katsoff D,
Summers-Chase D and Wilson C: Controlled ovarian hyperstimulation
adversely affects implantation following in vitro
fertilization-embryo transfer. J Assist Reprod Genet. 16:416–420.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toth B, Würfel W, Germeyer A, Hirv K,
Makrigiannakis A and Strowitzki T: Disorders of implantation - are
there diagnostic and therapeutic options? J Reprod Immunol.
90:117–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu XT, Fu P and Wang YP: Use of
traditional Chinese medicine in assisted reproductive technology.
Chinese Archives of Traditional Chinese Medicine. 27:120–123.
2009.(In Chinese).
|
|
21
|
Zhang JW, Lian F, Zheng S and Yan HL:
Effect of Erzhi Tiangui granules (traditional Chinese medicine) on
follicular fluid interleukin-1β, interleukin-6 concentration and
embryo quality in patients undergoing controlled ovarian
hyperstimulation. Reprod Contracept. 27:714–717. 2007.(In
Chinese).
|
|
22
|
Lian F, Teng YL, Zhang JW, et al: Clinical
study on Erzhi Tiangui granules combined with in vitro
fertilization-embryo transplant for treatment of 61 cases of
infertility. J Tradit Chin Med. 47:439–441. 2006.(In Chinese).
|
|
23
|
Huang ST and Chen AP: Traditional Chinese
medicine and infertility. Curr Opin Obstet Gynecol. 20:211–215.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kimber SJ: Leukaemia inhibitory factor in
implantation and uterine biology. Reproduction. 130:131–145. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhatt H, Brunet LJ and Stewart CL: Uterine
expression of leukemia inhibitory factor coincides with the onset
of blastocyst implantation. Proc Natl Acad Sci USA. 88:11408–11412.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smith AG, Heath JK, Donaldson DD, et al:
Inhibition of pluripotential embryonic stem cell differentiation
by. Nature. 336:688–690. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Williams RL, Hilton DJ, Pease S, et al:
Myeloid leukaemia inhibitory factor maintains the developmental
potential of embryonic stem cells. Nature. 336:684–687. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conquet F and Brûlet P: Developmental
expression of myeloid leukemia inhibitory factor gene in
preimplantation blastocysts and in extraembryonic tissue of mouse
embryos. Mol Cell Biol. 10:3801–3805. 1990.PubMed/NCBI
|
|
29
|
Murray R, Lee F and Chiu CP: The genes for
leukemia inhibitory factor and interleukin-6 are expressed in mouse
blastocysts prior to the onset of hemopoiesis. Mol Cell Biol.
10:4953–4956. 1990.PubMed/NCBI
|
|
30
|
Gearing DP, Thut CJ, VandeBos T, et al:
Leukemia inhibitory factor receptor is structurally related to the
IL-6 signal transducer, gp130. EMBO J. 10:2839–2848.
1991.PubMed/NCBI
|
|
31
|
Ware CB, Horowitz MC, Renshaw BR, et al:
Targeted disruption of the low-affinity leukemia inhibitory factor
receptor gene causes placental, skeletal, neural and metabolic
defects and results in perinatal death. Development. 121:1283–1299.
1995.PubMed/NCBI
|
|
32
|
Gale NW and Yancopoulos GD: Growth factors
acting via endothelial cell-specific receptor tyrosine kinases:
VEGFs, angiopoietins, and ephrins in vascular development. Genes
Dev. 13:1055–1066. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yancopoulos GD, Davis S, Gale NW, Rudge
JS, Wiegand SJ and Holash J: Vascular-specific growth factors and
blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Charnock-Jones DS, Kaufmann P and Mayhew
TM: Aspects of human fetoplacental vasculogenesis and angiogenesis.
I Molecular regulation. Placenta. 25:103–113. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaufmann P, Mayhew TM and Charnock-Jones
DS: Aspects of human fetoplacental vasculogenesis and angiogenesis.
II Changes during normal pregnancy. Placenta. 25:114–126. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Red-Horse K, Drake P and Fisher S: Human
pregnancy: the role of chemokine networks at the fetal-maternal
interface. Expert Rev Mol Med. 6:1–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hur SE, Lee JY, Moon HS and Chung HW:
Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic
endometrium in advanced endometriosis. Mol Hum Reprod. 12:421–426.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hanahan D: Signaling vascular
morphogenesis and maintenance. Science. 277:45–50. 1997. View Article : Google Scholar
|
|
39
|
Rabbani ML and Rogers PA: Role of vascular
endothelial growth factor in endometrial vascular events before
implantation in rats. Reproduction. 122:85–90. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Simón C, Cano F, Valbuena D, Remohí J and
Pellicer A: Implantation: Clinical evidence for a detrimental
effect on uterine receptivity of high serum oestradiol
concentrations in high and normal responder patients. Hum Reprod.
10:2432–2437. 1995. View Article : Google Scholar
|
|
41
|
Simón C, Garcia Velasco JJ, Valbuena D, et
al: Increasing uterine receptivity by decreasing estradiol levels
during the preimplantation period in high responders with the use
of a follicle-stimulating hormone step-down regimen. Fertil Steril.
70:234–239. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carson DD, Lagow E, Thathiah A, et al:
Changes in gene expression during the early to mid-luteal
(receptive phase) transition in human endometrium detected by
high-density microarray screening. Mol Hum Reprod. 8:871–879. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kao LC, Tulac S, Lobo S, et al: Global
gene profiling in human endometrium during the window of
implantation. Endocrinology. 143:2119–2138. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Horcajadas JA, Riesewijk A, Polman J, et
al: Effect of controlled ovarian hyperstimulation in IVF on
endometrial gene expression profiles. Mol Hum Reprod. 11:195–205.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gong X, Yu Y, Tong Q, Ren Y and Jin Z:
Effects of ‘Bu Shen Huo Xue Decoction’ on the endometrial
morphology and expression of leukaemia inhibitory factor in the rat
uterus during the oestrous cycle. Evid Based Complement Alternat
Med. 2013:4960362013. View Article : Google Scholar
|
|
46
|
Efferth T, Li PC, Konkimalla VSB and Kaina
B: From traditional Chinese medicine to rational cancer therapy.
Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
